Print this page

30th ISTH Congress

The scientific sessions of the Congress started on July 9th and continued through July 13th.

The 5 days included a prestigious list of 4 plenary speakers, 28 State of the art sessions on related topics, hundreds of talks and presenters, over 8000 global participants, 38 industry supported symposia, more than 1800 selected abstracts and more than 75 industry partners.

On July 10-12, 2022, the exposition area for industry was open to the audience. We showcased our Hemostasis Diagnostic Management portfolio. With a large, impressive booth, situated in a highly visible location on the floor, the Werfen booth was a beacon of quality, innovation and excellence for our customers and prospects.

While our ACL TOP Family 50 Series systems, with three primary models on display, were the initial focus for visitors entering the booth.

Additionally, visitors enjoyed a first-hand look at our HemoCell Specialized Lab Automation workcell, and even tried our virtual reality tour of a Hemostasis lab, featuring a customized HemoCell workcell. We were able to schedule 4 demonstrations to customers from sites with ongoing opportunities.

Rounding out our Hemostasis Diagnostics Management portfolio, Whole Blood Hemostasis products were also on display, including ROTEM sigma, VerifyNow, GEM Hemochron 100 and GEMweb Live.

On the educational side, Werfen hosted an educational Presentation Theater, entitled “ADAMTS13 and von Willebrand Axis,” with Ken Friedman, MD, of the Versiti Blood Center of Wisconsin, as the keynote speaker. With attendees spilling out the back of the theater, the presentation was wildly successful—once again, underlining our leadership in the field of Hemostasis!

isth

To check the floorplan of the congress: conferenceharvester.com/floorplan

Additional updates related to the ISTH:

  • The International Society on Thrombosis and Haemostasis (ISTH) is proud to announce the Impact Factor results for its two scientific publications, The Journal of Thrombosis and Haemostasis (JTH), which received a historically high Impact Factor of 16.036, and Research and Practice in Thrombosis and Haemostasis (RPTH), celebrating its fifth anniversary, scored a debut of 5.953.
  • The International Society on Thrombosis and Haemostasis (ISTH), welcomes Flora Peyvandi, M.D., Ph.D., as ISTH President for the 2022-2024 term. Peyvandi is a professor of internal medicine at the University of Milan and the Director of the Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center at the Internal Medicine-Hemostasis and Thrombosis Unit of the IRCCS Maggiore Hospital in Milan, Italy.
  • The 31st ISTH congress will officially be held on June 24-28, 2023 at the Palais des Congrés de Montréal.

 

Elias El Bouchi (Hemostasis Marketing Manager)

Last modified on Thursday, 08 September 2022 09:01